Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
about
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNSAntitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2Hybrid nanoparticles for detection and treatment of cancerMultifunctional nanoparticles for brain tumor imaging and therapy.Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and FullerenesProspects and applications of nanobiotechnology: a medical perspectiveDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug delivery.Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatmentNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Drug transport to brain with targeted nanoparticles.Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities.Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization.Synthesis and characterization of PLGA nanoparticles.Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactionsAugmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients.Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapiesPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.Challenges and opportunities in developing nanoparticles for detoxification.Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovirImpact of nanotechnology in cancer: emphasis on nanochemopreventionPolymer genomics: an insight into pharmacology and toxicology of nanomedicinesNerve growth factor delivery by ultrasound-mediated nanobubble destruction as a treatment for acute spinal cord injury in rats.Nanoparticles of biodegradable polymers for new-concept chemotherapy.Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.Review on Medusa:a polymer-based sustained release technology for protein and peptide drugs.Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.Paclitaxel Nano-Delivery Systems: A Comprehensive Review.The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsA relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.Manufacturing Techniques and Surface Engineering of Polymer Based Nanoparticles for Targeted Drug Delivery to Cancer.Nanoparticles: a promising modality in the treatment of sarcomas.Nanoparticles in biological systems.Challenges in development of nanoparticle-based therapeutics.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.Product quality for nanomaterials: current U.S. experience and perspective.Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery.The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
P2860
Q21262019-7BDE8F4F-DE80-4546-954E-4A0510D91BF2Q24649780-BEA2ADBE-EC9E-4347-807C-9AF79BBADC8AQ26849404-7B8C0AC3-5E41-4A6D-85E5-E9C57BE72E58Q26865418-C17F12EA-ED43-4E77-9E01-43638FECB023Q28386610-E1B10365-E813-4954-BAC0-11D6FA5B098AQ28387616-0D8ACD69-1DC8-46A2-B093-9BFC0D59B8EEQ30479638-4AACDBC5-4FD1-4FBA-9DCA-D894E6AA4CACQ30481085-99CD7D30-BCBD-4A53-9FB7-3C52AC949E85Q33306061-0322BD50-B791-4FEF-8356-3FFAD12853D2Q33726019-C2021E7A-27D7-4336-A66D-9F3537D3F65AQ33985140-61BDF681-16AC-4945-98C6-D0C5B5D45797Q34119493-EF33653E-BD99-4298-8FF1-275D2695F81FQ34482076-5F516320-496B-416E-9E25-A69590227E26Q34524402-61FB86C4-DEE5-4F4A-9933-9AD08271B98DQ34648464-62D1FAE4-DD3F-4C30-8AA4-538DA05BC59DQ35007929-3F972696-260C-4D0F-ABD7-3D7BA077BCCEQ35009191-9DF1CBC2-51A1-4F81-B035-60481A55099DQ35071594-E47BA73F-75D4-4375-A70D-E960F97E78EEQ35619316-27214EDD-7944-4DEC-AF42-ADC2D8BE4FEDQ35646236-AA24A86D-A831-4D0F-879A-FDEE1C1FEC98Q35750624-8FD0EB71-CC03-42EB-8A4B-B36667201865Q35754353-9C9ECCD1-DE86-46EC-B8ED-C558AF1A2BB0Q36303478-EDAA562A-7449-4B5A-80CE-2083E05B51ECQ36314934-D83D2584-448E-49DF-9729-074BB6B78E2BQ36654312-68EEF11A-8836-4604-AE63-18333D9A92FBQ36776906-07454A2E-E11C-4116-B454-DA6C3EA4A893Q36903816-BCBD0699-E3E9-4B5F-9A99-A79E32118AD7Q37148172-5F00B133-52C6-4D33-8F2F-1DCD70214EE0Q37250009-F1B8F63B-B542-4089-802D-A47781CD3A6FQ37289000-FC14F5CD-1247-4E67-AFAD-8DFFA1770DCFQ37413195-A13AF8D3-B459-4D64-80D5-E72EE6B3B5D3Q37636197-15635D1C-DFB1-4EAC-92F2-7EC77CAFD214Q37761069-AF52DB02-6844-4C26-B58C-B17DE8052CB4Q37835203-DD4A6EDC-B7B2-4C07-9D6E-AC568E5501BDQ37992525-837CBCE5-4333-4199-B018-3EDED306E202Q38177370-3B8464C6-4F79-49DF-817E-BC0081EF777FQ38340318-C0A808EB-A627-4EA0-A55C-A436F8176E4DQ38568248-77030EF2-E493-4D6F-9D06-68E7BD4E5606Q38731626-29AF6306-6F69-4DD3-92A7-A974835B9270Q38758194-B6A3740E-5C5C-48C0-8323-68220A3742E0
P2860
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@ast
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@en
type
label
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@ast
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@en
prefLabel
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@ast
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@en
P2093
P356
P1476
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
@en
P2093
Guofeng Huang
Khin Yin Win
Si-Shen Feng
P304
P356
10.2174/0929867043455909
P577
2004-02-01T00:00:00Z